World news – Dexcom and Nick Jonas Unveil First Super Bowl Commercial Calling For Better Care For People With Diabetes

With a socially distant Super Bowl Sunday, Dexcom is also offering fans the opportunity to « watch » the game with Nick Jonas on DexcomGameDay.com

DexCom, Inc. (NASDAQ: DXCM), the worldwide leader in continuous glucose monitoring for people with diabetes, today launched its first Super Bowl commercial starring multi-platinum recording artist, actor, and philanthropist Nick Jonas, diagnosed with Type 1 diabetes at age 13. The ad, which will run during Super Bowl LV on February 7, 2021, calls for better care for people with diabetes who still prick their fingers painfully to measure their glucose levels.

Nick Jonas wears the Dexcom G6 Continuous Glucose Monitoring (CGM) system. Photo courtesy of Dexcom. (Photo: Business Wire)

« Too many people with diabetes suffer from painful, outdated fingerprints because they don’t know there is a better way, » said Jonas. « I firmly believe that people with diabetes deserve the very best care, and that is really the spirit of my first Super Bowl commercial. It means a lot to me to share this message of awareness and the need for improved CGM access as possible as many people with diabetes as possible. « 

Dozens of millions of people with diabetes around the world are still pricking the fingers, indicating a lack of awareness and the need to improve access to breakthrough CGM technology, the revolutionized diabetes management.

The Dexcom G6 CGM System uses a small portable sensor and transmitter to measure glucose levels in real time and wirelessly send them to a compatible smart device or receiver * so no painful Fingerprints are required. † Dexcom CGM also displays trend arrows to show the speed and direction of glucose levels. This makes it easier to decide what treatment to take right now and helps people with diabetes avoid potentially dangerous high or low glucose events. ‡

The ad, which airs at the end of the first quarter, shows how far various technologies have advanced over the past 40 years – contrary to the realization that people with diabetes still prick their fingers for their glucose to measure, a method that was invented in 2015, 1970s.

« We’re excited to be working with Nick to shed light on technologies that we know will significantly affect the lives of people with diabetes said Chad Patterson, senior vice president of global marketing at Dexcom. « People with diabetes deserve the best of care. Together with leading diabetes advocacy groups, health professionals and payers, we’re trying to raise awareness and improve access to CGM. »

As COVID-19 persists, great Bowl parties this year are expected to look very different. For people with diabetes, having a group at higher risk of COVID-19-related complications, social distancing, and avoiding large gatherings is especially important. To help people feel less isolated on Super Bowl Sunday, Dexcom is offering fans the opportunity to « watch » Nick Jonas play through an interactive augmented reality experience.

Visit DexcomGameDay. com to see the commercial and find out how to watch the Super Bowl with Nick Jonas.

While the Super Bowl is a tremendous stage to start this important conversation, Dexcom and Nick Jonas will be in the coming weeks Work with leading diabetes nonprofits to continue the discussion on better awareness, education, and access for diabetes management technology. Organizations involved in this effort include Beyond Type 1, the non-profit co-founded by Nick, Children with Diabetes, the College Diabetes Network, JDRF International, and Taking Control of Your Diabetes.

DexCom, Inc. enables people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has grown to become a leader in diabetes care technology. By addressing the needs of patients, caregivers and clinicians, Dexcom simplifies and improves diabetes management around the world. For more information, visit www.dexcom.com.

† If your Dexcom G6 glucose warnings and readings do not match symptoms or expectations, use a blood glucose meter to help make diabetes management decisions.

‡ The urgent low may warn you of severe hypoglycemia soon, so you have time to take appropriate action before it happens.

Jordan Belfort says amateurs should « take their chips off the table » if retailer stocks fall .

Jordan Belfort, convicted felon and author of « The Wolf of Wall Street », warns of big money hedge funds and private investors after the GameStop phenomenon.

While local governments try to regulate the Adopting hazard payment for food workers push companies back, saying the extra pay is too costly to maintain. On Monday, Kroger blamed his decision to close a Ralphs supermarket and a Food 4 Less in Long Beach for a hazard pay measure.

The Alibaba (BABA) Group announced its results for the third quarter for December 31st known. The e-commerce giant saw sales jump 37% year over year and beat profit estimates.

Here’s a game many would love to play and make a billion dollars in a month? And nine investors just made it to GameStop stock.

Let’s talk about portfolio defense. After manipulating the Social Flash Mob Market over the past week, this topic should not be ignored. That doesn’t mean the markets are collapsing. After losing 2% to close last week’s Friday session, this week’s trading started on a positive tone as the S&P 500 rose 1.5% and the Nasdaq rose 2.5%. The underlying bullish factors – a more stable political scene steadily driving COVID vaccination programs – still play a role, even if not quite as strong as investors had hoped. While heightened volatility might linger with us for a while, it’s time to consider defensive stocks. And that will bring us to dividends. By providing a steady stream of income regardless of market conditions, a reliable dividend stock provides a pad for your investment portfolio when the stock stops growing in value. With that in mind, we used the TipRanks database to get three dividend stocks that yield 8%. However, that’s not all they offer. Each of these stocks received enough street praise to earn a consensus rating of « Strong Buy ». New Residential Investment (NRZ) First we examine the REIT sector, Real Estate Investment Trusts. These companies have long been known for dividends that are both high-yielding and reliable. Due to the company’s tax compliance, REITs are required to return a certain percentage of profits directly to shareholders. NRZ, a medium-sized company with a market capitalization of $ 3.9 billion, has a diverse portfolio of residential mortgages, original loans, and mortgage loan service rights. The company is based in New York City. NRZ has a $ 20 billion investment portfolio that has generated dividends of $ 3.4 billion since its inception. The portfolio has proven resilient in the face of the corona crisis, and after a difficult first quarter last year, NRZ posted rising gains in the second and third quarters. The most recently reported third quarter showed GAAP earnings of $ 77 million, or 19 cents per share. Although this EPS was lower than in the previous year, it was a strong trend reversal compared to the 21 cent loss reported in the previous quarter. The rising income has enabled NRZ to raise the dividend. The Q3 payment was 15 cents per common share; The dividend for the fourth quarter was increased to 20 cents per common share. At this rate, the dividend annualizes to 80 cents, making an impressive 8.5%. In a further move to return profits to investors, the company announced in November that it had approved share buybacks of $ 100 million. BTIG analyst Eric Hagen is impressed with New Residential – especially the company’s solid balance sheet and liquidity. “[We] like the ability to potentially build capital through retained earnings while maintaining a competitive payout. We believe the dividend increase underscores the company’s liquidity position. We believe that NRZ has been able to release capital as it has raised approximately $ 1 billion in securitized debt for its MSR portfolio through two separate transactions since September, ”said Hagen. In line with his comments, Hagen rates NRZ as a buy and its target price of $ 11 implies an upward movement of 17% for the year ahead. (To see Hagen’s track record, click here.) It’s not often that all analysts agree on a stock. When this happens, take note of it. NRZ’s consensus rating for strong buy is based on unanimous 7 purchases. The stock’s average target price of $ 11.25 indicates an upward movement of ~ 20% from the current stock price of $ 9.44. (See NRZ stock analysis on TipRanks) Saratoga Investment Corporation (SAR) With the next stock we switch to the investment management area. Saratoga specializes in mid-market debt, capital appreciation and equity, with over $ 546 million under management. Saratoga’s portfolio is broad, including industry, software, waste disposal and home security. Saratoga has seen a slow but steady recovery from the corona crisis. The company’s sales declined in the first quarter of 20 and have grown slowly since then. The report for the third quarter of the fiscal year, published in early January, showed $ 14.3 million. Adjusted for taxes before taxes, Saratoga’s net investment income of 50 cents per share exceeded its 47-cents forecast by 6%. They say the race is slowly and steadily winning, and Saratoga has shown investors a generally stable hand over the past year. The stock has rallied 163% from its low after the corona last March. And the dividend, which the company cut in the second quarter, has increased twice since then. The current dividend of 42 cents per common share was declared for payment on February 10 last month. The annualized payment of $ 1.68 gives a return of 8.1%. The analyst Mickey Schleien from Ladenburg Thalmann is optimistic about Saratoga and writes: “We believe that the SAR portfolio is relatively defensive and focuses on software, IT services, education services and the CLO. SAR’s CLO remains up-to-date and the company is seeking refinancing / appreciation that we believe could positively affect our guidance. The analyst continued, « Our model assumes that SAR will use cash and SBA debt to fund net portfolio growth. We believe the Board of Directors will continue to increase the dividend given the performance of the portfolio, the existence of undistributed taxable income and the economic benefits of the Covid-19 vaccination program. “To this end, Schleien rates SAR a Buy along with a price target of USD 25. This number implies an upward trend of 20% from the current level. (To see Schleien’s track record, click here.) Wall Street analysts approve of Schleien on this stock. The other three registered ratings are buys, and the analyst consensus rating is a strong buy. Saratoga’s shares trade for $ 20.87 with an average target price of $ 25.50, indicating an upward movement of 22% over the next 12 months. (See SAR stock analysis on TipRanks) Hercules Capital (HTGC) Last but not least, Hercules Capital is a venture capital company. Hercules provides early stage funding support to small client businesses with a scientific background. Hercules’ customers are Life Life, Technology and Financial SaaS. Since its inception in 2003, Hercules has invested over $ 11 billion in more than 500 companies. The quality of the Hercules portfolio is evident from the company’s recent performance. The stock has fully rebounded from last winter’s corona crisis, rebounding 140% from its low last April. The result has also recovered. For the first nine months of 2020, HTGC posted net investment income of $ 115 million, or 11% more than the same period in 2019. For dividend investors, the key point is that net investment income covered the distribution – in fact, it was 106% of the Base distribution. The company was confident enough to kickstart sales with an additional 2 cents payment. The combined payout results in an annualized payment of $ 1.28 per common share and a yield of 8.7%. In yet another vote of confidence, Hercules completed a $ 100 million investment grade bond offering in November, raising capital for debt repayments, new investments and corporate purposes. The bonds were offered in two tranches, each valued at $ 50 million. The bonds mature in March 2026. Analyst Crispin Love covers Piper Sandler stock and sees plenty to love in HTGC. “We continue to believe that HTGC’s focus on fast-growing technology and life science companies positions the company well in the current environment. In addition, Hercules is not dependent on a COVID recovery as it does not invest in « vulnerable » sectors. Hercules also has a strong liquidity position which should allow the company to act quickly when it finds attractive investment opportunities, « commented Love. All of the above convinced Love to rate HTGC as an outperform (i.e. buy). In addition to the call, he also set a target price of $ 16, indicating upside potential of 9%. (To see Love’s track record, click here.) The stock’s recent appreciation has pushed Hercules stock up to its average target price of $ 15.21 and only ~ 4% above the trading price of $ 14.67 calmly. Wall Street doesn’t seem to mind, however, as the analysts’ consensus rating is a unanimous strong buy based on 6 recent buy-side ratings. (See HTGC stock analysis on TipRanks.) To find great ideas for trading dividend stocks at attractive valuations, visit TipRanks ‘Best Stocks to Buy, a newly launched tool that brings together all of TipRanks’ stock insights. Disclaimer: The opinions expressed in this article are solely those of the presented analysts. The content is intended to be used for informational purposes only. It is very important that you do your own research before making any investment.

DraftKings is one of the top IPO stocks to watch as gambling legalization gains momentum. Here’s what the fundamentals and technical analysis are saying about buying DKNG stock right now.

In your search for the best artificial intelligence stocks to buy, identify companies like Microsoft, Netflix, and Nvidia, use AI technology to improve products or gain a strategic advantage.

Pfizer stock rose Tuesday after the pharmaceutical company posted adjusted earnings of 42 cents per share for the fourth quarter ended December 31 on sales of $ 11.68 billion.

United Parcel Service Inc. gained 3.7% in morning trade, enough to boost profits for the Dow Jones Transportation Average after the parcel delivery giant reported better than expected fourth quarter results earlier. In the conference call with analysts after the win, the managing director Carol Tomé said: « So let’s just talk to the elephant in the room who is our biggest customer. » Of 19 million customers, Tomé said Amazon.com Inc. is the largest. The e-commerce giant’s share of total revenue rose from 11.6% in 2019 to 13.3% in 2020. UPS reported total sales of $ 84.63 billion in 2020, indicating Amazon’s year In 2020, sales were $ 11.26 billion, compared with $ 8.59 billion in the previous year. UPS stocks are up 1.6% over the past three months, while Amazon stocks are up 13.9%, Dow Transports are up 10.8%, and the Dow Jones Industrial Average is up 13.4 %.

(Bloomberg) – Exxon Mobil Corp. has pledged to secure its mammoth dividend after posting its first annual loss in at least 40 years. This is a sign of defiance from an oil drill that has been besieged by activist investors, lawmakers and climate change activists. Exxon assured investors of its financial health in a world of $ 50 a barrel of oil and promised that if crude oil fell to $ 45 it would sacrifice spending in the name of dividends. The largest oil explorer in the western world has so far avoided the kind of payout cuts made by rivals Royal Dutch Shell Plc and BP Plc. The dividend commitment follows a write-off of US natural gas and other assets of $ 19.3 billion and the lowest production since the Mobil Corp. merger. 1999. Cash flow from operating activities – a key measure of the company’s strength – declined nearly 9% to $ 4 billion in the last three months of 2020. Looked beyond all of that, investors rose 2% to $ 45.82 New York at 9:33 a.m. Exxon’s $ 15 billion a year payout has a 7.56% return and is the third highest on the S&P 500 index. Giacomo Romeo, a London-based analyst at Jefferies International Ltd., said in a telephone interview, that the dividend was covered by oil at a rate of $ 50 per barrel. Excluding the historical impairment, Exxon returned to earnings in the fourth quarter, earning 3 cents per share and finishing a run of three consecutive quarterly losses. This is comparable to the Bloomberg Consensus estimate for a 2 cents profit. Exxon emerges from the rubble of 2020 as it faces the worst crisis in its modern history. In addition to increasing criticism of the environmental balance sheet, financial performance has deteriorated. Exxon hasn’t increased its payouts since early 2019. « We continue to focus on adding long-term value to our shareholders, » said CEO Darren Woods in a statement. « Last year was one of the toughest market conditions ExxonMobil has ever seen. » The pressure exerted by last year’s drop in prices led Woods to hold preliminary talks with his counterpart at Chevron Corp. led on a mega-merger, the Wall Street Journal reported on Sunday. Following assurances on Tuesday, some investors feared the oil titan might cut back to support its cash position. As recently as October, the company promised to increase the payouts. That all changed a month later, however, when management brushed the word « grow » out of the dividend discussion. To learn more about Exxon’s newest director, click here Facing Serious Challenges Even When Commodities Are At Risk. Chevron disappointed investors at the end of recent weakness with a surprise loss based on weaker than expected refining margins. The previous Tuesday, BP Plc had made a small profit that was only a fraction of what the explorer had made in days leading up to the pandemic. ConocoPhillips posted a third straight loss. As he begins his fifth year as CEO, Woods takes an ax on capital expenditures and operating costs, and almost foregoes his 2018 blueprint to increase production while drilling and construction costs have been low. Exxon announced 14,000 job cuts, delayed mega-projects from the Permian Basin to Mozambique and promised to keep spending under control by the middle of this decade. To explore Bloomberg Intelligence’s ESG insights and data, click here. The cuts have helped turn Wall street analysts on the stock, especially given the rebound in oil prices this year, but investors are still seeing deep losses after falling 41% in 2020 and years of underperformance relative to peers . Exxon on Monday announced plans to start a new business called ExxonMobil Low Carbon Solutions, which will spend $ 3 billion on low-carbon technologies through 2025. The projects included several previously announced initiatives. From what Bloomberg Intelligence says, Exxon Mobil’s investment withdrawal may not be enough to protect its $ 15 billion dividend. It can likely sustain a dividend through 2021, but at the expense of long-term returns. A countercyclical investment strategy has all but stalled, but the company is still operating on cash. – Fernando Valle and Brett Gibbs, BI analysts. Read the report here. Last week, activist investor Engine # 1 officially took up a change in strategy that added four directors to the board ahead of Exxon’s annual meeting in May. The investor, supported by the California State Teachers’ Retirement System, urges Exxon to invest more in clean energy, to commit to reducing emissions and improving ROI. In the meantime, the company is in talks with the investor D.E. Shaw & Co., which, according to people familiar with the matter, could result in additional director nominations in the coming weeks. On Tuesday, Exxon appointed former Petronas CEO Tan Sri Wan Zulkiflee Wan Ariffin to its board and said it was speaking to other candidates for directors. (Updates stock price in fourth paragraph, adds analyst’s comment in fifth paragraph.) For more articles like this, please visit us at bloomberg.com. Sign up now to stay up to date with the most trusted business news source. © 2021 Bloomberg LP

Li Auto Inc. shares fell 3.2% in premarket trading Tuesday after the China-based electric vehicle maker announced overnight that January deliveries were up from the Had more than quadrupled in the previous year. Li’s report comes a day after other China-based EV manufacturers reported shipments in January that saw Nio Inc. up 352% and Xpeng Inc. up 470%. Li shipments increased 356% to 5,379 Li ONE SUVs. Separately, the company announced that it has set up a new research and development center in Shanghai aimed at developing EV technologies such as high-voltage platforms, ultra-fast charging technologies, and autonomous driving technologies. Li’s shares are up 40.0% in the past three months through Monday, while Nio’s shares are up 71.0%, XPeng’s shares are up 138%, and the S&P 500 is up 14.0% GameStop (GME) has extended its losses from yesterday and is down as much as 50% in the early trading day on Tuesday.

The video game retailer’s shares closed 30% on Monday after the shares came under massive pressure from retail investors on Reddit’s WallStreetBets forum last month.

The trading volume on Monday was about a third of the average of the last five sessions, according to Bloomberg.

The pharmaceutical company expects sales of around $ 15 billion from sales of its Covid-19 vaccine this year Wall Street reckoned at $ 12.7 billion.

(Bloomberg) – BioCryst Pharmaceuticals Inc. hit a five-year high when Reddit investors gathered to call out a « #BioWar » for the bears behind Launching a heavily shorted biotechnology developing rare disease drugs ended experimental therapy for Covid-19, which rose 39% on Monday after a poster on Reddit’s WallStreetBets forum listed it as “the most undervalued stock the market, ”while another said a brewery- # BioWar wanted“ to stick to the shorts in a massive way. “Little to no revenue biotech companies have long been the focus of short betting on Wall Street and may emerge as the new focus for retail investors who rebel against elite hedge funds. The battlefield, however, is an already crowded arena with hedge funds positioned on either side. BioCryst is a short target with a short sale of around 17%, or $ 259 million, according to S3 Partners, a financial analysis firm. But it’s also a hedge fund choice held by Citadel, well-known biotech company Baker Bros. Advisors LP, and activist Alex Denner of Sarissa Capital Management. Prior to Monday’s rally, BioCryst stocks had already shrugged their shoulders on Covid-19 study, which is backed by the National Institutes of Health. The company is expected to have sales of less than $ 31 million for the full year 2020. Another short-selling biotech, Novavax Inc., has also generated interest on chat forums, which could benefit funds such as RA Capital Management and Perceptive Advisors that have interests in the firm. The stock has more than doubled in the past few trading days, albeit due to late-stage positive results for vaccine candidate Covid-19. The short position at Novavax is $ 1.5 billion, according to S3. During the pandemic, biotech companies looking for the next Covid-19 treatment or vaccine caught the imagination of retail investors. Dynavax Technologies Corp. added another $ 436 million in market value on Monday after it was revealed that they had both initiated a mid-stage Covid vaccine trial with a partner and that the UK had exercised the option to get more vaccinations from another Dynavax partner using the company’s adjuvant to order. Inovio Pharmaceuticals Inc. also rose sharply on Monday after Twitter users filed a filing about BlackRock Inc.’s stake in the company. A tweet said BlackRock had doubled its position, although Bloomberg data shows the percentage is virtually unchanged. Meanwhile, the motivation behind the Reddit-powered rally of 131% was at Healthier Choices Management Corp. unclear on Monday as Twitter users said this was an opportunity to send a hedge agent « on the run ». However, there does not appear to be a brief interest in the sub-penny inventory that makes vaping products and operates health food stores in Florida. The biggest owners of the micro-cap were the management team. (Updates on adding Covid-19 stock games as well as details on trading healthier choices) For more articles like this, visit bloomberg.com. Sign up now to stay ahead of the curve with the most trusted company in News Source. © 2021 Bloomberg LP

Li Auto, along with Nio and Xpeng Motors, had strong sales in January suggesting that the Chinese electric vehicle market will not pause after the 2020 boom.

Major stock indices rose Tuesday morning as stocks of top retailer stocks, including GameStop, posted some of their recent gains. General Electric Company (NYSE: GE) stocks traded a little higher on Monday, according to a Wall Street analyst had an in-depth look at the company’s free cash flow prospects. GE Analyst: Bank of America analyst Andrew Obin reiterated his buy recommendation on GE and raised his price target from $ 13 to $ 14. See Also: Buying Bank of America Stock The GE Thesis: GE stocks rose last week after the company posted better-than-expected industrial free cash flow of $ 4.37 billion and an industrial FCF between Jan. , $ 5 billion, and $ 4.5 billion respectively on Monday, Obin said GE’s 3% year-over-year fourth-quarter drop in orders was also a pleasant surprise, as orders were down 28% in the previous quarter. The midpoint of GE’s commercial FCF forecast for 2021 of $ 3.5 billion was also slightly above Bank of America’s target of $ 3.3 billion. Obin said investors don’t seem to be fully appreciating GE’s multi-year effort to reduce factoring, which was a $ 3.2 billion outflow in 2020. That process is now coming to an end, and Obin says investors can expect working capital to gradually normalize. Related Link:, 000, 5 Years Later: How Much Would General Electric Stock Be Worth? Obin is aware of the caution towards GE amid the uncertain economic outlook and the company’s rough recent track record, but believes the company is overly cautious with its aviation sales projections for 2021. In the meantime, Obin said, GE has a lot of financial flexibility in the short term and could actually benefit from rising interest rates. Rising interest rates would help reduce GE’s pension liability by $ 25.5 billion and GE Capital’s pension liability by $ 21.3 billion. « Higher discount rates would lower the value of these long-lived debt, » Obin said. Gasoline Gas Take: GE appears to have stopped the bleeding by aggressively addressing its liquidity and balance sheet issues, and it has implemented a long-term turnaround plan. Obin, however, is forecasting just 62 cents for earnings per share in 2023, which suggests GE is already trading at 17.2 times earnings in 2023, even if the company hits Obins’ growth targets over the next two years . Photo Credit: Momoneymoproblemz, via Wikimedia Commons Latest Reviews For GE DateFirmActionFromTo Jan 2021Morgan StanleyMaintainsOverweight Dec 2020DZ BankUpgradesSellHold Dec 2020Morgan StanleyMaintainsOverweight See More Analyst Ratings For GE See The Latest Analyst Ratings For More Info From BenzingaClick Would Be Worth General Stock Options Here From BenzingaClick Here For Options Trades From Benzinga Electric? © 2021 Benzinga.com. Benzinga does not offer investment advice. All rights reserved.

Moderna has become a strong competitor following the approval of a coronavirus vaccine. But the Moderna share remains on a wild ride. Is Moderna stock a buy now?

Inovio Pharmaceuticals rose sharply on Tuesday as retail investors gathered on the online messaging platform Reddit and targeted the pharmaceutical industry. Plymouth Meeting, Pennsylvania, stocks rose 12% in premarket trading to $ 19. Inovio also got a boost after New York money manager BlackRock increased its stake in the company.